Advisory Services Network buys $2,536,215 stake in Johnson & Johnson (JNJ)

Johnson & Johnson (JNJ) : Advisory Services Network scooped up 8,634 additional shares in Johnson & Johnson during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Apr 21, 2016. The investment management firm now holds a total of 22,381 shares of Johnson & Johnson which is valued at $2,536,215.Johnson & Johnson makes up approximately 0.68% of Advisory Services Network’s portfolio.

Johnson & Johnson closed down -0.14 points or -0.12% at $112.77 with 57,59,301 shares getting traded on Wednesday. Post opening the session at $112.96, the shares hit an intraday low of $112.46 and an intraday high of $113.2 and the price fluctuated in this range throughout the day.Shares ended Wednesday session in Red.

Other Hedge Funds, Including , Strs Ohio sold out all of its stake in JNJ during the most recent quarter. The investment firm sold 2,077,111 shares of JNJ which is valued $235,378,219.National Investment Services Inc Wi boosted its stake in JNJ in the latest quarter, The investment management firm added 266 additional shares and now holds a total of 28,335 shares of Johnson & Johnson which is valued at $3,210,922. Johnson & Johnson makes up approx 3.59% of National Investment Services Inc Wi’s portfolio.Private Bank Trust Co boosted its stake in JNJ in the latest quarter, The investment management firm added 581 additional shares and now holds a total of 29,234 shares of Johnson & Johnson which is valued at $3,312,797. Johnson & Johnson makes up approx 0.57% of Private Bank Trust Co’s portfolio.Tnb Financial boosted its stake in JNJ in the latest quarter, The investment management firm added 3,300 additional shares and now holds a total of 73,788 shares of Johnson & Johnson which is valued at $8,129,962. Johnson & Johnson makes up approx 2.43% of Tnb Financial’s portfolio.Capital Insight Partners boosted its stake in JNJ in the latest quarter, The investment management firm added 322 additional shares and now holds a total of 32,694 shares of Johnson & Johnson which is valued at $3,562,665. Johnson & Johnson makes up approx 3.64% of Capital Insight Partners’s portfolio.

On the company’s financial health, Johnson & Johnson reported $1.68 EPS for the quarter, beating the analyst consensus estimate by $ 0.03 according to the earnings call on Apr 19, 2016. Analyst had a consensus of $1.65. The company had revenue of $17482.00 million for the quarter, compared to analysts expectations of $17491.02 million. The company’s revenue was up .6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.56 EPS.

Many Wall Street Analysts have commented on Johnson & Johnson. Company shares were Reiterated by RBC Capital Mkts on Apr 20, 2016 to “Outperform”, Firm has raised the Price Target to $ 125 from a previous price target of $122 .Company shares were Reiterated by Piper Jaffray on Apr 20, 2016 to “Neutral”, Firm has raised the Price Target to $ 106 from a previous price target of $105 .Company shares were Reiterated by RBC Capital Mkts on Apr 15, 2016 to “Outperform”, Firm has raised the Price Target to $ 122 from a previous price target of $114 .

Johnson & Johnson is a holding company. The Company is engaged in the research and development manufacture and sale of a range of products in the health care field. The Company has more than 265 operating companies conducting business around the world. The Company’s primary focus is products related to human health and well-being. The Company is organized into three business segments: Consumer Pharmaceutical and Medical Devices. The Company’s subsidiaries operate 134 manufacturing facilities occupying approximately 21.5 million square feet of floor space. The Company’s research facilities are located in the United States Belgium Brazil Canada China France Germany India Israel Japan the Netherlands Singapore Switzerland and the United Kingdom.

Leave a Reply

Johnson & Johnson - Is it time to Sell?

Top Brokerage Firms are advising their investors on Johnson & Johnson. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.